Ilias et al. observed lower age-normalized IGF-1 in critically ill and non-surviving COVID-19 patients and inverse correlations of IGF-1 with markers of severity and with age in their cohort, suggesting that low IGF-1 associates with worse outcomes [106]. This evidence concerns the gene IGF1 and COVID-19.